10-Q/A: NEXT-ChemX Corporation Faces Going Concern Doubts Amidst Restated Financials and Share Ownership Dispute

Sentiment:

Quarterly Report Amendment


NEXT-ChemX Corporation's latest 10-Q/A filing reveals a significant accumulated deficit, ongoing losses, and substantial doubt about its ability to continue as a going concern, compounded by a legal battle over a large block of its common shares.

Delay expectedThe company's filings were delayed and required restatement due to its former auditors, BF Borgers CPA PC, being denied the privilege of practicing before the SEC, necessitating a review and reaudit by new auditors.The Debt Extension Agreements with key employees and consultants, which defer payment of significant amounts owed, indicate delays in remuneration payments due to funding difficulties.The Debt Extension Agreements have a suspensive condition that means they will only enter into force after May 30, 2026, if certain shareholder debt conditions are met, implying a delay in formalizing these debt deferrals and conversions.
Capital raiseThe company explicitly states it will need to raise an estimated $3 million during fiscal 2024 to manage its business needs.Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from directors, and/or the private placement of common stock.The Debt Extension Agreements with employees and consultants grant them the right to convert all or a portion of their indebtedness and penalty interest to shares of common stock at a discounted price, indicating a potential future equity issuance for debt settlement.
Worse than expectedThe net loss increased to $556,408 in Q1 2024 from $457,973 in Q1 2023, indicating worsening profitability.The accumulated deficit grew significantly to $7,068,518, reflecting continued and increasing losses.Total liabilities increased substantially, including new non-current notes payable, indicating increased financial leverage and debt burden.The company explicitly states 'substantial doubt regarding the Company’s ability to continue as a going concern,' which is a critical negative indicator.Internal control over financial reporting was deemed 'still not effective,' highlighting ongoing material weaknesses.The company recorded an unrealized loss on its investment in Clontarf shares, reflecting a negative market performance of a key financial asset.The legal dispute over 15,866,096 common shares and the termination of the transfer agent represent a severe and unexpected corporate and legal challenge.

Summary

  • The company filed an amended Quarterly Report (10-Q/A) due to its former auditors, BF Borgers CPA PC, being denied the privilege of practicing before the SEC, necessitating a review and reaudit by new auditors, Fruci & Associates II PLLC.
  • A key financial adjustment involved reclassifying the iTDE Technology intangible asset from indefinite to finite life, resulting in a $495,592 adjustment to its value and a $187,227 amortization charge as of March 31, 2024.
  • The balance sheet was readjusted to include $308,365 of retained earnings, and Commitments and Contingencies are now reported as a separate line item.
  • The company reported a net loss of $556,408 for the three months ended March 31, 2024, an increase from $457,973 for the same period in 2023.
  • Operating expenses rose to $519,581 in Q1 2024 from $436,653 in Q1 2023, partly due to a strategic shift towards using lower-cost consultants in India and increased third-party expert costs.
  • Cash on hand increased to $94,770 as of March 31, 2024, from $2,458 at December 31, 2023, primarily due to $385,000 in new notes and loans.
  • The company's accumulated deficit grew to $7,068,518 as of March 31, 2024, from $6,512,110 at December 31, 2023.
  • Total liabilities significantly increased to $4,526,557 as of March 31, 2024, from $3,932,425 at December 31, 2023, including $365,000 in new non-current notes payable.
  • Management expressed substantial doubt about the company's ability to continue as a going concern, citing persistent losses and difficulty raising capital.
  • The company is engaged in a legal dispute concerning a Third Turnover Order from a Texas court, which mandated the transfer of 15,866,096 of its common shares to a receiver, a decision the company and its attorneys believe is illegal and is currently under appeal.
  • Seven directors, officers, and employees are owed a total of $2,232,636 in deferred salaries, remuneration, and expenses as of March 31, 2024, with Debt Extension Agreements allowing for conversion of this debt into common stock at a discount under certain conditions.

Sentiment

Score: 2

Explanation: The sentiment is highly negative due to significant and increasing financial losses, a stated 'going concern' doubt, substantial accumulated deficit, heavy reliance on related-party debt, and a major ongoing legal dispute over share ownership. While there is operational progress with pilot plants, the severe financial and legal challenges overshadow these developments, indicating high risk and instability.

Positives

  • Cash on hand increased significantly to $94,770 as of March 31, 2024, from $2,458 at December 31, 2023, due to new financing.
  • Cash used in operating activities slightly decreased to $292,688 in Q1 2024 from $310,145 in Q1 2023.
  • The company successfully appointed a new registered public accounting firm, Fruci & Associates II PLLC, to replace its former auditors, BF Borgers CPA PC, and completed required financial statement reviews and reaudits.
  • Progress is being made on the construction of two pilot plant systems for the iTDE Technology in India, with the smaller system expected to be completed during Q3 2025.
  • A 50:50 joint venture with Clontarf Energy plc for the deployment of iTDE Technology in Bolivia has advanced, with the partnership being approved for Phase 3 of the YLB convocatoria process.
  • A wage claim from a former consultant for $7,292 was dismissed by the Illinois Department of Labor on May 15, 2024.

Negatives

  • The company incurred a net loss of $556,408 for Q1 2024, an increase from $457,973 in Q1 2023.
  • Operating expenses increased by $82,928 in Q1 2024 compared to Q1 2023, partly due to increased consultant costs and accrued unused vacation time.
  • The accumulated deficit grew to $7,068,518 as of March 31, 2024, indicating continued unprofitability.
  • Total liabilities increased significantly to $4,526,557 as of March 31, 2024, from $3,932,425 at December 31, 2023.
  • The company has a working capital deficit and has found it difficult to raise money on capital markets, relying extensively on existing shareholders and accumulating significant debt to employees and consultants.
  • Management expressed substantial doubt about the company's ability to continue as a going concern, requiring an estimated $3 million in additional capital during fiscal 2024.
  • Internal control over financial reporting was deemed 'still not effective' as of March 31, 2024, with material weaknesses identified.
  • The company recorded an unrealized loss of $19,987 on its shareholding in Clontarf Energy plc during Q1 2024 due to a decline in share price.
  • Intellectual property protection strategy has been scaled back in the near term due to a lack of funding.

Risks

  • Substantial doubt exists regarding the company's ability to continue as a going concern due to accumulated losses and insufficient funding.
  • The company requires an estimated $3 million in additional capital during fiscal 2024, with no assurance that such financing will be available.
  • Reliance on existing shareholders and related parties for funding creates financial vulnerability and potential for significant dilution if debt is converted to equity.
  • The effectiveness of internal control over financial reporting is 'still not effective' as of March 31, 2024, indicating material weaknesses that could affect financial reporting reliability.
  • The ongoing legal dispute over the Third Turnover Order, which resulted in the transfer of 15,866,096 common shares, poses a significant threat to the company's share structure and could lead to further litigation or financial instability.
  • The Debt Extension Agreements with key employees and consultants, which allow for debt conversion to equity at a discount, could lead to significant shareholder dilution if activated.
  • The company's ability to achieve revenues is dependent on the completion of its pilot plants and successful commercialization of the iTDE Technology, which is still in development.
  • Delays in pilot plant completion or commercialization could exacerbate financial difficulties and going concern issues.
  • The company has scaled back its intellectual property protection strategy due to funding constraints, potentially exposing its core technology to greater risk.

Future Outlook

Management anticipates further losses before the commercialization of the iTDE system can be expected to break-even or turn a profit. The company believes it will identify further commercialization opportunities once pilot demonstrations become a reality, which is expected to ease the working capital deficit. The first pilot plant system is expected to be completed during the third quarter of 2025, with large container-sized samples of actual brines expected to arrive in India around October 2024 for testing. The company plans to open new corporate offices and commence the organization of its initial production facility within the next six months.

Management Comments

  • "The Company was made aware that its long standing auditors, BF Borgers CPA PC, had been denied the privilege of appearing or practicing before the Securities and Exchange Commission (the SEC) as an accountant. In view of the nature of the actions taken by the SEC in relation to the Companys former auditor, the SEC required the Company to have its new auditors review 2 years of its quarterly financial statements along with the reaudit of 2 years of annual financial statements. This has resulted in a deficiency in the Companys filings entirely due to circumstances beyond the control of the Company."
  • "Matters relating to projected timing in the Report have been changed from the original disclosure better to reflect the current belief of management regarding such projections."
  • "Management anticipates more losses before the commercialization of the system can be expected to break-even or to turn a profit."
  • "Management believes that the Companys capital requirements will depend on many factors including the continuing and expanding success of the Companys development efforts, however, it is anticipated that the Company will require additional capital."
  • "Management intends to finance operating costs over the next twelve months with existing cash on hand, loans from directors and, or the private placement of common stock. There can be no assurances that managements plans will be successful."
  • "The refocus of employment reflected by these changes represents a change in the strategy of the Company in general towards using lower cost expertise particularly focused on India to drive forward work on the iTDE System pilot plant."
  • "Management considers it preferable to focus on this work [pilot plant completion], and this has led to an overall reduction in expenses prior to reengaging in other activities."
  • "The Company and its attorneys believe the Turnover Order is illegal for reasons stated in a brief timely filed by attorneys for Benton Wilcoxon and NextMetals Ltd with the Texas Court of Appeals."

Industry Context

NEXT-ChemX Corporation operates in the nascent but critical direct lithium extraction (DLE) and broader ion extraction technology sector. This industry is driven by the global demand for lithium for electric vehicle batteries and renewable energy storage, as well as the need for more sustainable and environmentally friendly mining and water treatment solutions. The company's iTDE Technology aims to offer a competitive advantage by avoiding evaporation ponds, reducing energy costs, and targeting specific ions, positioning itself as a 'green' alternative. Its partnership with Clontarf Energy plc for Bolivian lithium projects places it in a region with significant brine resources, but also complex political and operational landscapes. The focus on India for pilot plant development suggests a strategy to leverage lower-cost R&D and manufacturing capabilities.

Comparison to Industry Standards

  • The company's iTDE Technology aims to differentiate itself from traditional lithium extraction methods (e.g., evaporation ponds) by offering a more environmentally friendly and sustainable process, avoiding large evaporation ponds and reducing energy costs, which aligns with growing industry demand for ESG-compliant solutions.
  • The company's current financial state, characterized by zero revenue, significant accumulated deficit ($7,068,518), and a 'going concern' warning, is far from industry standards for established companies and is typical of early-stage R&D companies in the DLE space that require substantial capital investment before commercialization.
  • The reliance on related-party debt and the accumulation of significant unpaid remuneration to employees and consultants ($2,232,636) is not a standard practice for well-capitalized companies and indicates severe funding challenges compared to peers who might secure institutional funding.
  • The legal dispute over 15,866,096 common shares and the termination of the transfer agent due to this issue are highly unusual and represent a significant corporate governance and operational challenge not typically seen in stable, publicly traded companies.
  • The company's engagement with Clontarf Energy plc and participation in the YLB convocatoria in Bolivia positions it alongside other DLE technology providers vying for access to significant lithium resources, such as Lilac Solutions, EnergyX, and Summit Nanotech, though NEXT-ChemX is at an earlier stage of commercial validation.
  • The strategic shift to conduct R&D and pilot plant construction in India to leverage lower-cost expertise is a common strategy for early-stage technology companies seeking to optimize development costs, similar to how many tech companies outsource development.

Management Changes

RolePrevious PersonNew PersonEffective DateReason
Corporate SecretaryUnknown (resigned)J. Michael Johnson (President & CFO)2024-01-26Resignation of previous Corporate Secretary.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Internal Control EffectivenessManagement concluded its internal control over financial reporting was 'still not effective' as of March 31, 2024, despite significant improvement, due to identified material weaknesses.2024-03-31Indicates ongoing risks to the reliability of financial reporting and potential for misstatements. The company relies on officers/employees using personal funds for company expenses, which impacts efficiency and transparency.
Auditor ChangeAppointed Fruci & Associates II PLLC as new registered public accounting firm to replace BF Borgers CPA PC, who were denied the privilege of practicing before the SEC.2024-05-03Necessary step to comply with SEC requirements and restore audit credibility, but highlights past issues with financial oversight.
Transfer Agent TerminationTerminated Empire Stock Transfer Inc. as its transfer agent on May 23, 2024, after Empire indicated intent to issue shares covered by a disputed Turnover Order.2024-05-23A highly unusual and disruptive event that could complicate share transfers and investor relations, stemming from a significant legal dispute over share ownership.

Legal Proceedings

  • A wage claim for $7,292 filed by a former consultant with the Illinois Department of Labor was dismissed on May 15, 2024.
  • A Third Turnover Order was entered on April 26, 2024, by a Texas court, requiring the company to turn over 15,866,096 of its common shares to a receiver. The company and its attorneys believe this order is illegal and it is currently on appeal with the Texas Court of Appeals for the 11th District.
  • The company terminated its transfer agent, Empire Stock Transfer Inc., on May 23, 2024, after Empire proceeded to cancel and reissue the disputed 15,866,096 shares despite the ongoing appeal and the company's objections.

Related Party Transactions

  • The company continues to rely on advances from related parties, primarily through the nonpayment of all or a portion of salary payments to senior Directors, Officers, consultants, and employees, which effectively constitutes deferred debt.
  • As of March 31, 2024, seven Directors, Officers, and employees, including full-time consultants, were owed a total of $2,232,636 for salaries, remuneration, and expenses.
  • Of this amount, $364,415 is owed to the two Senior Managers (Benton Wilcoxon, Director, CEO; and John Michael Johnson, Director, President & CFO).
  • Debt Extension Agreements concluded on February 29, 2024, with these seven individuals allow for the conversion of their outstanding debt and penalty interest into common stock at a discount (5% lower than the 5-day average trading price or 5% lower than a reported public offering price).
  • If all outstanding debt ($2,232,636) as of March 31, 2024, were converted at the then-average 5-day trading price of $4.50, it would result in the issuance of 496,141 shares, indicating potential significant dilution.
  • These Debt Extension Agreements have a suspensive condition, meaning they will only enter into force after May 30, 2026, if total debt to non-employee shareholders is converted, paid in full, or forgiven; as of June 30, 2025, none had entered into force.

Stakeholder Impact

  • **Shareholders**: Face significant dilution risk from potential debt-to-equity conversions by related parties and future capital raises. The ongoing legal dispute over 15,866,096 shares creates uncertainty regarding ownership and potential share price volatility. The 'going concern' warning indicates a high risk of investment loss.
  • **Employees/Consultants**: Many key personnel have accumulated significant deferred debt ($2,232,636) due to unpaid remuneration, impacting their financial stability. While Debt Extension Agreements offer a path to conversion, their activation is conditional and delayed, creating uncertainty.
  • **Creditors**: The company has substantial outstanding payables ($162,373), accrued expenses ($513,800), and loans payable ($1,330,000 to shareholders), indicating a high risk of delayed or non-payment given the going concern issues.
  • **Customers/Partners (e.g., Clontarf Energy plc)**: The company's financial instability and legal challenges could impact its ability to deliver on commercialization agreements and joint ventures, potentially delaying or jeopardizing projects like the Bolivian lithium extraction.
  • **Regulatory Authorities (SEC)**: The company has faced scrutiny due to auditor issues and is subject to ongoing reporting requirements and potential enforcement actions related to financial controls and disclosures.

Next Steps

  • Complete the construction of the first of two pilot plant systems in India, with the smaller flexible system expected during Q3 2025.
  • Conduct extraction tests on brine solutions, starting with synthetic brines based on analytical data from the Bolivian State Lithium Company.
  • Receive large container-sized samples of actual brines in India around October 2024 for pilot plant testing.
  • Continue engagement with an Indian company to test the effectiveness of their nano-filtration system for use with the pilot plant.
  • Advance through Phase 3 of the YLB convocatoria process in Bolivia, which involves assessing the financial capacity of bidders.
  • Raise an estimated $3 million in capital during fiscal 2024 to manage business needs, potentially through director loans or private placement of common stock.
  • Address the material weaknesses in internal control over financial reporting and continue to improve the control environment.
  • Pursue the appeal of the Third Turnover Order in the Texas Court of Appeals for the 11th District in Eastland, Texas.
  • Open new corporate offices and commence the organization of its initial production facility within the next six months.

Key Dates

DateDescription
2014-08-13Company incorporated under the laws of the State of Nevada.
2021-04-01Company changed its business entirely with the acquisition of intellectual property assets related to iTDE Technology.
2021-09-30iTDE Technology asset reclassified as an intangible asset of indefinite life (later restated).
2021-12-23Company filed SEC Form 8-12G, becoming a mandatory filer.
2022-12-31Carrying amount of iTDE Technology was $3,150,114.
2023-01-01Start of the three months ended March 31, 2023, for financial comparison.
2023-03-16Wage claim filed by former consultant with Illinois Department of Labor.
2023-03-18Effective date of former consultant's resignation; company paid $5,833 as final remuneration.
2023-03-27Partnership Agreement signed between the Company and Clontarf Energy plc.
2023-04-21Receipt of first income from the commencement of commercialization of iTDE Technology.
2023-05-31Acquisition date of shares in Clontarf Energy plc at a market price of GBP 0.00085.
2023-07-27Former consultant sent notice maintaining demand for full $7,292.
2023-12-31End of fiscal year 2023; carrying amount of iTDE Technology was $2,691,967.
2024-01-01Start of the three months ended March 31, 2024, for financial reporting.
2024-01-26Corporate Secretary resigned and was replaced by the Company's President.
2024-02-21Company formed a Nevada LLC as a 50:50 joint venture with Clontarf Energy plc for Bolivia deployment.
2024-02-29Seven senior employees and consultants agreed to defer payment of $2,232,636 in outstanding amounts through Debt Extension Agreements.
2024-03-04Clontarf submitted qualification materials for the partnership to YLB for the Call for Bids for seven priority salares in Southern Bolivia.
2024-03-31End of the quarterly period covered by this report; total assets $2,882,639, total liabilities $4,526,557, accumulated deficit $(7,068,518).
2024-04-26Judge Elizabeth Leonard entered a Third Turnover Order requiring the company to turn over 15,866,096 common shares.
2024-05-03Company became aware that its long-standing auditors, BF Borgers CPA PC, had been denied the privilege of appearing or practicing before the SEC.
2024-05-14YLB confirmed Clontarf in the partnership as one of the twenty-one approved companies moving into phase three of the convocatoria process.
2024-05-15Wage claim case dismissed by the Illinois Department of Labor.
2024-05-23Company terminated Empire Stock Transfer Inc. as its transfer agent via email and letter.
2024-07-15Original filing date of the Quarterly Report on Form 10-Q, now replaced by this 10-Q/A.
2024-10-01Expected arrival of large container-sized samples of actual brines in India for pilot plant testing.
2025-04-28Company's 2023 Annual Report filed on Form 10-K/A, incorporating restatement results.
2025-05-19Company's first quarter report on Form 10-Q/A filed.
2025-05-30Addendum signed with signatories of Debt Extension Agreements, setting a suspensive condition for their entry into force.
2025-06-11Average 5-day trading price of company's shares was $5.16.
2025-06-27Number of shares outstanding of common stock was 28,546,834.
2025-06-30Filing date of this Quarterly Report on Form 10-Q/A.
2025-09-14Due date for two loans totaling $250,000.
2025-09-30Expected completion of the smaller flexible pilot plant system.
2026-05-30Deadline for suspensive condition for Debt Extension Agreements to enter into force.
2027-02-28Deadline for company to achieve certain financial metrics (EBITDA or quarterly income) or declare indebtedness due, as per Debt Extension Agreements.
2029-03-01Fifth anniversary of Debt Extension Agreements execution, when indebtedness becomes due.

Recommendation

strong sell

Keywords

Lithium extraction, iTDE Technology, Direct Lithium Extraction, SEC filing, 10-Q/A, Quarterly Report, Financial statements, Going concern, Intangible assets, Pilot plant, Brine processing, Corporate governance, Legal proceedings, Related party transactions, Financial deficit, Capital raise, CHMX, NEXT-ChemX Corporation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.